共 108 条
[1]
Naringenin prevents experimental liver fibrosis by blocking TGFβ-Smad3 and JNK-Smad3 pathways[J]. Erika Hernández-Aquino,Natanael Zarco,Sael Casas-Grajales,Erika Ramos-Tovar,Rosa E Flores-Beltrán,Jonathan Arauz,Mineko Shibayama,Liliana Favari,Víctor Tsutsumi,José Segovia,Pablo Muriel.World Journal of Gastroenterology. 2017(24)
[2]
Molecular pathogenesis and clinical consequences of iron overload in liver cirrhosis[J]. Katarzyna Sikorska,Agnieszka Bernat,Anna Wróblewska.Hepatobiliary & Pancreatic Diseases International. 2016(05)
[5]
Alcoholic disease: Liver and beyond
[J].
World Journal of Gastroenterology,
2014, (40)
:14652-14659
[6]
Role of Nrf2 in chronic liver disease[J]. Wei Tang,Yong-Fang Jiang,Murugavel Ponnusamy,Mamadou Diallo.World Journal of Gastroenterology. 2014(36)
[7]
Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis[J]. Mirko Tarocchi,Simone Polvani,Giada Marroncini,Andrea Galli.World Journal of Gastroenterology. 2014(33)
[8]
Oxidative stress and antioxidants in hepatic pathogenesis[J]. Hye-Lin Ha,Hye-Jun Shin,Mark A Feitelson,Dae-Yeul Yu.World Journal of Gastroenterology. 2010(48)
[9]
Isolated mangiferin and naringenin exert antidiabetic effect via PPAR γ /GLUT4 dual agonistic action with strong metabolic regulation[J] . Ashok K. Singh,Vinit Raj,Amit K. Keshari,Amit Rai,Pranesh Kumar,Atul Rawat,Biswanath Maity,Dinesh Kumar,Anand Prakash,Arnab De,Amalesh Samanta,Bolay Bhattacharya,Sudipta Saha.Chemico-Biological Interactions . 2018
[10]
Navel orange peel hydroethanolic extract, naringin and naringenin have anti-diabetic potentials in type 2 diabetic rats[J] . Osama M. Ahmed,Mohamed A. Hassan,Sanaa M. Abdel-Twab,Manal N. Abdel Azeem.Biomedicine & Pharmacotherapy . 2017